12/8/2023 0 Comments Auxl stock![]() Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Auxilium Pharmaceuticals Inc (AUXL) since 2010 are shown in Table 1 and Table 2. The stock of Auxilium Pharmaceuticals (NASDAQ:AUXL), a specialty biopharmaceutical company, corrected almost 45 in the last 10 months from its 52-week high at 25.54 in the absence of any. So, be cautious in the near-term, but because the company seems poised for long term growth, I would be a buyer anytime the stock crosses significantly below the 14.50 institutional sale price. Company List - A AUXL Insider Trading activities at Auxilium Pharmaceuticals Inc (AUXL). Although the stock price has plenty of room to move higher long-term, its near-term movement should hover around the $14.50 institutional sale price. 1. At Stock Options Channel, our YieldBoost formula has looked up and. If you happened to buy this stock just last week in the mid-14’s you may want to take some profits and repurchase the stock at a later time. Investors in Auxilium Pharmaceuticals Inc (NASD: AUXL) saw new options begin trading this week, for the November 16th expiration. AUXL stock price reacted very favorably to the news on Friday, posting a 7.44% gain up $1.08 to $15.59. The offering is expected to close on or before June 13. ![]() The offer is supposed to net proceeds of about $49.9 million, which will be used for general corporate purposes, including working capital, product development and capital expenditures. View the latest AUXL stock reddit and Twitter threads at MarketBeat. ( NASDAQ: AUXL) said it agreed to sell about 3.7 million shares of stock for $14.50 per share to some institutional investors. After the bell on Thursday, specialty biotech drug developer Auxilium Pharmaceuticals Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |